Astec Lifesciences Beneish M-Score Historical Data
The historical data trend for Astec Lifesciences's Beneish M-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Astec Lifesciences Beneish M-Score Chart
|
Astec Lifesciences Annual Data
|
|
Trend |
Mar15 |
Mar16 |
Mar17 |
Mar18 |
Mar19 |
Mar20 |
Mar21 |
Mar22 |
Mar23 |
Mar24 |
| Beneish M-Score |
|
Get a 7-Day Free Trial
|
|
|
-3.20 |
-2.05 |
-1.89 |
-2.80 |
-2.44 |
|
Astec Lifesciences Quarterly Data
|
|
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
Jun24 |
Sep24 |
Dec24 |
| Beneish M-Score |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
-2.44 |
- |
- |
- |
Competitive Comparison of Astec Lifesciences's Beneish M-Score
For the Agricultural Inputs subindustry, Astec Lifesciences's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Astec Lifesciences's Beneish M-Score Distribution in the Agriculture Industry
For the Agriculture industry and Basic Materials sector, Astec Lifesciences's Beneish M-Score distribution charts can be found below:
* The bar in red indicates where Astec Lifesciences's Beneish M-Score falls into.
Astec Lifesciences Beneish M-Score Calculation
The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.
The M-Score Variables:
The M-score of Astec Lifesciences for today is based on a combination of the following eight different indices:
| M | = | -4.84 | + | 0.92 * DSRI | + | 0.528 * GMI | + | 0.404 * AQI | + | 0.892 * SGI | + | 0.115 * DEPI |
| = | -4.84 | + | 0.92 * 1.4997 | + | 0.528 * 1.2046 | + | 0.404 * 0.8768 | + | 0.892 * 0.7294 | + | 0.115 * 1.1389 |
| - | 0.172 * SGAI | + | 4.679 * TATA | - | 0.327 * LVGI |
| - | 0.172 * 0.6772 | + | 4.679 * -0.05862 | - | 0.327 * 1.1151 |
| = | -2.44 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
| This Year (Mar24) TTM: | Last Year (Mar23) TTM: |
Total Receivables was ₹1,696 Mil.
Revenue was ₹4,582 Mil.
Gross Profit was ₹1,349 Mil.
Total Current Assets was ₹3,985 Mil.
Total Assets was ₹9,749 Mil.
Property, Plant and Equipment(Net PPE) was ₹5,316 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹363 Mil.
Selling, General, & Admin. Expense(SGA) was ₹98 Mil.
Total Current Liabilities was ₹3,972 Mil.
Long-Term Debt & Capital Lease Obligation was ₹1,990 Mil.
Net Income was ₹-469 Mil.
Gross Profit was ₹0 Mil.
Cash Flow from Operations was ₹102 Mil.
|
Total Receivables was ₹1,551 Mil.
Revenue was ₹6,282 Mil.
Gross Profit was ₹2,227 Mil.
Total Current Assets was ₹4,989 Mil.
Total Assets was ₹9,794 Mil.
Property, Plant and Equipment(Net PPE) was ₹4,292 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹337 Mil.
Selling, General, & Admin. Expense(SGA) was ₹198 Mil.
Total Current Liabilities was ₹5,262 Mil.
Long-Term Debt & Capital Lease Obligation was ₹109 Mil.
|
1. DSRI = Days Sales in Receivables Index
Measured as the ratio of Revenue in Total Receivables in year t to year t-1.
A large increase in DSR could be indicative of revenue inflation.
| DSRI | = | (Receivables_t / Revenue_t) | / | (Receivables_t-1 / Revenue_t-1) |
| = | (1696.252 / 4581.807) | / | (1550.731 / 6281.662) |
| = | 0.370215 | / | 0.246866 |
| | = | 1.4997 |
2. GMI = Gross Margin Index
Measured as the ratio of gross margin in year t-1 to gross margin in year t.
Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.
| GMI | = | GrossMargin_t-1 | / | GrossMargin_t |
| = | (GrossProfit_t-1 / Revenue_t-1) | / | (GrossProfit_t / Revenue_t) |
| = | (2227.326 / 6281.662) | / | (1348.628 / 4581.807) |
| = | 0.354576 | / | 0.294344 |
| | = | 1.2046 |
3. AQI = Asset Quality Index
AQI is the ratio of asset quality in year t to year t-1.
Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.
| AQI | = | (1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) | / | (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1) |
| = | (1 - (3984.914 + 5315.831) / 9749.283) | / | (1 - (4988.525 + 4291.719) / 9794.142) |
| = | 0.046007 | / | 0.05247 |
| | = | 0.8768 |
4. SGI = Sales Growth Index
Ratio of Revenue in year t to sales in year t-1.
Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.
| SGI | = | Sales_t | / | Sales_t-1 |
| = | Revenue_t | / | Revenue_t-1 |
| = | 4581.807 | / | 6281.662 |
| | = | 0.7294 |
5. DEPI = Depreciation Index
Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.
DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.
| DEPI | = | (Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) | / | (Depreciation_t / (Depreciaton_t + PPE_t)) |
| = | (336.525 / (336.525 + 4291.719)) | / | (362.534 / (362.534 + 5315.831)) |
| = | 0.072711 | / | 0.063845 |
| | = | 1.1389 |
Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.
6. SGAI = Sales, General and Administrative expenses Index
The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.
SGA expenses index > 1 means that the company is becoming less efficient in generate sales.
| SGAI | = | (SGA_t / Sales_t) | / | (SGA_t-1 /Sales_t-1) |
| = | (97.643 / 4581.807) | / | (197.666 / 6281.662) |
| = | 0.021311 | / | 0.031467 |
| | = | 0.6772 |
7. LVGI = Leverage Index
The ratio of total debt to Total Assets in year t relative to yeat t-1.
An LVGI > 1 indicates an increase in leverage
| LVGI | = | ((LTD_t + CurrentLiabilities_t) / TotalAssets_t) | / | ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1) |
| = | ((1990 + 3971.588) / 9749.283) | / | ((108.625 + 5261.994) / 9794.142) |
| = | 0.61149 | / | 0.54835 |
| | = | 1.1151 |
8. TATA = Total Accruals to Total Assets
Total accruals calculated as the change in working capital accounts other than cash less depreciation.
| TATA | = | (IncomefromContinuingOperations_t | - | CashFlowsfromOperations_t) | / | TotalAssets_t |
| = | (NetIncome_t - NonOperatingIncome_t | - | CashFlowsfromOperations_t) | / | TotalAssets_t |
| = | (-469.295 - 0 | - | 102.21) | / | 9749.283 |
| | = | -0.05862 |
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Astec Lifesciences has a M-score of -2.44 suggests that the company is unlikely to be a manipulator.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NSE:ASTEC has been successfully added to your